5/1/19: ADDING MULTIMEDIA Levita Magnetics Announces Expanded Indication of Magnetic Surgical System for Use in Prostatectomy Procedures
Levita Magnetics announced that the U.S. Food and Drug Administration has granted the company an expanded indication to market the first-of-its-kind Levita® Magnetic Surgical System for use in prostatectomy procedures. Initially indicated for use in laparoscopic cholecystectomy (gallbladder removal) and bariatric surgical procedures, the shaftless Magnetic Surgical System reduces the number of incisions necessary for minimally invasive procedures.
Levita® Magnetics Announces Publication of Clinical Data for Magnetic Surgical System for Less Invasive Bariatric Surgery
1/31/19: The study, titled “Magnetic Liver Retraction: an Incision-Less Approach for Less Invasive Bariatric Surgery,” concluded that magnetic retraction is a novel approach that allows a safe, reproducible, incision-less technique for port-less intra-abdominal mobilization. The device successfully permitted optimal liver retraction during laparoscopic bariatric surgery, facilitating surgical exposure while decreasing the number of abdominal incisions.
Levita Magnetics Announces FDA Clearance of Expanded Indication for Magnetic Surgical System for Use in Bariatric Procedures
Initially indicated for use in gallbladder removal procedures, the shaftless Magnetic Surgical System reduces the number of incisions necessary for the indicated procedures.
